Form 4: Acadia Pharmaceuticals Executive James Kihara Reports Stock Transactions
SEC Form 4 Filing
Principal Accounting Officer James Kihara of Acadia Pharmaceuticals reports acquisition and disposal of common stock and restricted stock units.
Summary
- On May 1, 2024, James Kihara, Principal Accounting Officer of Acadia Pharmaceuticals, acquired 2,596 shares of common stock through the vesting of restricted stock units.
- Also on May 1, 2024, Kihara disposed of 2,596 shares.
- On May 2, 2024, Kihara sold 1,326 shares of common stock at a weighted average price of $16.94, with prices ranging from $16.94 to $17.03.
- Following these transactions, Kihara directly owns 14,370 shares of common stock and 7,788 restricted stock units.
- The sales on May 2, 2024, were to cover withholding taxes related to the vesting of restricted stock units and were conducted under a Rule 10b5-1(c) plan.
- The restricted stock units vest in four equal annual installments beginning May 1, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of restricted stock units vesting and acquisition of common stock. |
| 05/01/2024 | First vesting date of restricted stock units in four equal annual installments. |
| 05/02/2024 | Date of common stock sale to cover withholding taxes. |
| 05/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.